Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferry endosomal RAB5 effector complex subunit 3 is a cytoplasmic protein-coding gene found in humans, encoded by the C12orf4 gene. It is a critical part of the FERRY complex, which mediates the interaction between RAB5A, mRNA molecules, and ribosomes for endosomal mRNA transport. It plays a role in mast cell degranulation and endosomal localization of specific mRNAs, and is highly conserved across species. Variations in the gene are linked to autosomal recessive intellectual disability, but the protein is not currently established as a direct therapeutic or pharmacological target. It is classified as a component of a multi-protein effector complex, rather than as a receptor, enzyme, or similar druggable protein class[1][8].
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferry endosomal RAB5 effector complex subunit 3 (FERRY3).